Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Net Income (2020 - 2025)

Historic Net Income for Roivant Sciences (ROIV) over the last 5 years, with Q4 2024 value amounting to $327.0 million.

  • Roivant Sciences' Net Income rose 65886.52% to $327.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was $327.0 million, marking a year-over-year increase of 271511.4%. This contributed to the annual value of $373.2 million for FY2025, which is 21841.62% up from last year.
  • As of Q4 2024, Roivant Sciences' Net Income stood at $327.0 million, which was up 65886.52% from -$43.1 million recorded in Q3 2024.
  • Roivant Sciences' Net Income's 5-year high stood at $327.0 million during Q4 2024, with a 5-year trough of -$384.9 million in Q4 2022.
  • Moreover, its 5-year median value for Net Income was -$101.1 million (2021), whereas its average is -$141.6 million.
  • In the last 5 years, Roivant Sciences' Net Income crashed by 116711.8% in 2021 and then soared by 65886.52% in 2024.
  • Roivant Sciences' Net Income (Quarter) stood at -$275.6 million in 2020, then dropped by 11.06% to -$306.1 million in 2021, then decreased by 25.75% to -$384.9 million in 2022, then skyrocketed by 84.8% to -$58.5 million in 2023, then soared by 658.87% to $327.0 million in 2024.
  • Its last three reported values are $327.0 million in Q4 2024, -$43.1 million for Q3 2024, and $89.1 million during Q2 2024.